Schedule of Operating and Reportable Segments |
The tables below summarize information about our reportable segments.
| | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2024 | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | Total segment revenues* | 232,316 | | | $ | 34,826 | | | | | $ | 267,142 | | Cost of sales | 105,559 | | | 15,561 | | | | | 121,120 | | Gross profit | 126,757 | | | 19,265 | | | | | 146,022 | | Advertising and marketing | 33,753 | | | 5,612 | | | | | 39,365 | | Contribution margin | $ | 93,004 | | | $ | 13,653 | | | | | $ | 106,657 | | Other operating expenses | | | | | | | 34,611 | | Operating income | | | | | | | $ | 72,046 | | * Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2023 | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | Total segment revenues* | $ | 246,143 | | | $ | 33,166 | | | | | $ | 279,309 | | Cost of sales | 110,076 | | | 14,560 | | | | | 124,636 | | Gross profit | 136,067 | | | 18,606 | | | | | 154,673 | | Advertising and marketing | 31,401 | | | 4,830 | | | | | 36,231 | | Contribution margin | $ | 104,666 | | | $ | 13,776 | | | | | $ | 118,442 | | Other operating expenses | | | | | | | 33,248 | | Operating income | | | | | | | $ | 85,194 | | * Intersegment revenues of $1.4 million were eliminated from the North American OTC Healthcare segment. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Schedule of Revenues from Similar Product Groups |
The tables below summarize information about our segment revenues from similar product groups. | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2024 | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | Analgesics | $ | 27,011 | | | $ | 1,282 | | | | | $ | 28,293 | | Cough & Cold | 14,961 | | | 5,736 | | | | | 20,697 | | Women's Health | 50,495 | | | 4,083 | | | | | 54,578 | | Gastrointestinal | 44,287 | | | 13,728 | | | | | 58,015 | | Eye & Ear Care | 43,319 | | | 4,811 | | | | | 48,130 | | Dermatologicals | 31,603 | | | 1,752 | | | | | 33,355 | | Oral Care | 17,674 | | | 3,100 | | | | | 20,774 | | Other OTC | 2,966 | | | 334 | | | | | 3,300 | | | | | | | | | | Total segment revenues | $ | 232,316 | | | $ | 34,826 | | | | | $ | 267,142 | |
| | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2023 | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | Analgesics | $ | 27,182 | | | $ | 842 | | | | | $ | 28,024 | | Cough & Cold | 20,374 | | | 6,052 | | | | | 26,426 | | Women's Health | 54,955 | | | 4,956 | | | | | 59,911 | | Gastrointestinal | 44,681 | | | 12,910 | | | | | 57,591 | | Eye & Ear Care | 39,471 | | | 4,021 | | | | | 43,492 | | Dermatologicals | 34,678 | | | 1,338 | | | | | 36,016 | | Oral Care | 21,726 | | | 3,022 | | | | | 24,748 | | Other OTC | 3,076 | | | 25 | | | | | 3,101 | | | | | | | | | | Total segment revenues | $ | 246,143 | | | $ | 33,166 | | | | | $ | 279,309 | |
|